April 20, 2009
Mitsubishi Tanabe Pharma Corporation (MTPC) was obliged to voluntarily recall Medway 5% and 25% following the discovery of application data falsification. Medway was launched in May 2008 as the world's first recombinant human serum albumin product developed for therapeutic use...read more